VJOncology is committed to improving our service to you

ESMO 2020 | PRINCEPS study: atezolizumab for resectable NSCLC

VJOncology is committed to improving our service to you

Benjamin Besse

Benjamin Besse, MD, PhD, Institut Gustave Roussy, Villejuif, France, discusses results from the PRINCEPS study (NCT02994576), a Phase II clinical trial studying neoadjuvant atezolizumab for resectable non-small cell lung cancer (NSCLC). Results showed that surgery after one infusion of atezolizumab was safe and that the short delay between atezolizumab and surgery might explain the absence of major pathological response. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter